LivaNova (LIVN) Other Accumulated Expenses (2025 - 2026)
LivaNova's (LIVN) quarterly Other Accumulated Expenses came in at $385.0 million in Q2 2026, down 1.85% year-over-year from $392.3 million in Q2 2025, and down 1.15% quarter-over-quarter from $389.5 million in Q1 2026.
Powered by 
Analysis
LivaNova (LIVN) Other Accumulated Expenses (2025 - 2026) Analysis & Trends
LivaNova has disclosed Other Accumulated Expenses across 2 years of filings, most recently posting $385.0 million for Q2 2026.
- In Q2 2026, Other Accumulated Expenses fell 1.85% year-over-year to $385.0 million; the TTM figure through Jun 2026 stood at $385.0 million (down 1.85% YoY), while the FY2025 annual figure was $396.2 million, changed N/A from the prior year.
- Other Accumulated Expenses came in at $385.0 million for Q2 2026 at LivaNova, down from $389.5 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $396.2 million in Q4 2025 to a low of $360.4 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 385.02 Mn |
| Mar 31, 2026 | 389.49 Mn |
| Dec 31, 2025 | 396.24 Mn |
| Sep 30, 2025 | 394.59 Mn |
| Jun 30, 2025 | 392.27 Mn |
| Mar 31, 2025 | 360.39 Mn |